Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
9.28
-0.27 (-2.83%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $121.14 million. The enterprise value is $120.67 million.

Market Cap 121.14M
Enterprise Value 120.67M

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024, after market close.

Earnings Date Nov 6, 2024
Ex-Dividend Date n/a

Share Statistics

Annovis Bio has 13.05 million shares outstanding. The number of shares has increased by 22.09% in one year.

Shares Outstanding 13.05M
Shares Change (YoY) +22.09%
Shares Change (QoQ) +4.46%
Owned by Insiders (%) 21.56%
Owned by Institutions (%) 7.55%
Float 10.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.24

Current Ratio 1.24
Quick Ratio 0.99
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -453.01% and return on invested capital (ROIC) is -269.05%.

Return on Equity (ROE) -453.01%
Return on Assets (ROA) -183.39%
Return on Capital (ROIC) -269.05%
Revenue Per Employee n/a
Profits Per Employee -$2.69M
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +14.17% in the last 52 weeks. The beta is 1.72, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y) 1.72
52-Week Price Change +14.17%
50-Day Moving Average 8.60
200-Day Moving Average 9.12
Relative Strength Index (RSI) 54.36
Average Volume (20 Days) 350,902

Short Selling Information

The latest short interest is 1.36 million, so 10.41% of the outstanding shares have been sold short.

Short Interest 1.36M
Short Previous Month 1.20M
Short % of Shares Out 10.41%
Short % of Float 13.27%
Short Ratio (days to cover) 5.96

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -40.88M
Pretax Income -47.53M
Net Income -43.02M
EBITDA n/a
EBIT -40.88M
Earnings Per Share (EPS) -$5.26
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 4.00M
Total Debt n/a
Net Cash 4.00M
Net Cash Per Share $0.31
Equity (Book Value) -1.75M
Book Value Per Share -0.15
Working Capital 989,116
Full Balance Sheet

Cash Flow

Operating Cash Flow -29.14M
Capital Expenditures n/a
Free Cash Flow -29.14M
FCF Per Share -$2.23
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.09%
Shareholder Yield -22.09%
Earnings Yield -34.51%
FCF Yield -23.38%

Analyst Forecast

The average price target for Annovis Bio is $29.67, which is 219.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target $29.67
Price Target Difference 219.72%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1